left-arrow right-arrow pinterest facebook google_plus linkedin

Other Trials

The following listings are our current trials. If you have questions or want to learn more about the trial, please contact us and provide the Methodist Health System Trial Code listed with the description.


Breast Cancer Registry

Status: Recruiting | Phase: Not Applicable

Official Title: Integrated Cancer Repository for Cancer Research (iCaRe2) – Breast Cancer Collaborative Repository

Study Purpose: This registry/tissue bank focuses on the collection of detailed information and biological samples on subjects to help create a resource that will be helpful to cancer researchers to study risk factors for a number of different types of cancer and other diseases, which relate to cancer. Learn more


ECOG-ACRIN EAY131

Status: Recruiting | Phase: Not Applicable 

Official Title: Screening For Treatment Assignment Based On Genetic Testing

Study Purpose: To evaluate the proportion of patients with objective response to targeted study agent(s) in patients with advanced refractory cancers/lymphomas/multiple myeloma. Learn more.


Head and Neck Cancer Registry

Status: Recruiting | Phase: Not Applicable 

Official Title: Integrated Cancer Repository for Cancer Research (iCaRe2)

Study Purpose: To gather information, tissue, and blood samples from patients that have been diagnosed with head and neck cancer to be used for future research and analysis. Learn more.


NCI COVID

Status: Recruiting | Phase: Not Applicable 

Official Title: NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study

Study Purpose: Researchers will use these blood samples, information, and medical images to answer the questions: How does COVID-19 affect the outcomes of people undergoing cancer treatment and how does having cancer affect COVID-19?  Learn more.


Pharmatech 516-001

Status: Available | Phase IB

Official Title: A Phase I/Ib Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Study Purpose: To identify how much MGCD516 can safely be administered to subjects, how much study drug is absorbed after taking MFCD516 capsules orally and how quickly the study drug is cleared from the blood stream. Learn more.


Thyroid Cancer Registry

Status: Recruiting | Phase: Not Applicable 

Official Title: Development and Implementation of the Thyroid Cancer Collaborative Registry (TCCR)

Study Purpose: To gather information, tissue, and blood samples from patients that have been diagnosed with thyroid cancer to be used for future research and analysis. Learn more.